Claims for Patent: 4,661,491

Summary for Patent: 4,661,491

Title:	Alfuzosine compositions and use
Abstract:	A method for treating humans or non-human animals for dysuria comprising administering an effective non-toxic amount of alfuzosine or a pharmaceutically acceptable salt thereof to a human or non-human animal suffering dysuria.
Inventor(s):	Regnier; Francois (Nancy, FR)
Assignee:	Synthelabo (Paris, FR)
Application Number:	06/867,031
Patent Claims:	1. A method for treating humans or non-human animals for dysuria comprising administering an effective dysuria controlling, non-toxic amount of alfuzosine or a pharmaceutically acceptable salt thereof to a human or non-human animal suffering dysuria. 2. A method according to claim 1 comprising administering alfuzosine hydrochloride. 3. A method according to claim 1 comprising administering from 0.5 to 10 mg of alfuzosine or the corresponding amount of a pharmaceutically acceptable salt thereof. 4. A method according to claim 1 for treating dysuria in patients having bladder neck disease or a neurological disorder. 5. A method according to claim 1 for treating dysuria in male patients having benign hypertrophy of the prostrate of alpha-adrenergic origin.